Category: ACN Newswire

康基醫療控股有限公司與Knight Bidco Limited今日聯合宣佈，擬通過協議安排（"建議交易"）對公司進行私有化。康基醫療控股有限公司私有化要約：每股9.25港元的註銷價較股份於截至未受干擾日期（即2025年6月30日）之收盤價溢價約21.7%，較股份於截至未受干擾日期（包括該日）止360個交易日在聯交所所報的平均收盤價溢價約47.3%，且超過了2022年以來於聯交所錄得之最高收盤價。本次私有化擬以協議安排實施，要約人及其一致行動人士合共持有公司74.75%之股份；已獲得一家機構股東作出的不可撤銷承諾，將投票支持該私有化方案。該方案為股東提供明確機會，使其能夠於康基醫療控股有限公司之股份持續面臨交易價格壓力及流動性受限之際，變現其於公司之權益。香港，2025年8月13日 - (亞太商訊 via SeaPRwire.com) - 2025年8月12日，康基醫療控股有限公司（「康基醫療」或「公司」，股份代號：9997.HK）與KNIGHT BIDCO LIMITED「要約人」今日聯合宣佈，雙方擬以協議安排的方式對公司進行私有化，以期公司能夠專注於長期戰略決策，包括研發長期投入及運營升級。待該方案完成後，公司將成為要約人的全資附屬公司，而公司股份於聯交所的上市地位將被撤銷。要約人由以下成員組成的財團全資持有：鍾先生與申屠女士（創始人）、TPG實體、NewQuest V基金及Al-Rayyan Holding。交易理據鑒於股票的交易價格持續承壓且流動性長期不足，公司從股票市場籌集資金的能力受到嚴重限制。除此之外，本公司為維持上市地位須承擔行政、合規及其他與上市相關之成本及開支，故維持上市地位之裨益有限。由於國內市場競爭加劇及持續之監管不確定性，為實現可持續增長，公司之長期策略需進行重大投資，此舉可能對短期財務表現造成壓力。預計需將額外資源分配至以下領域：銷售與市場推廣、研發及商業化投資，以及中國境外之市場擴張。鑒於維持上市地位之裨益有限，且涉及相關上市成本，康基醫療繼續維持上市地位之必要性已顯著降低。此外，該方案之實施將緩解公司短期財務表現所受壓力，從而更專注於戰略目標之推進。公司預期需要配置更多資源，以保障其未來可持續發展。此外，該方案為少數股東提供具吸引力之機會，使其能在市場波動、行業及宏觀不確定性，以及股份流動性有限之情況下，實現可觀回報。KNIGHT BIDCO LIMITED提出的私有化方案為康基醫療及其股東提供了及時有效的解決方案，提議將康基醫療私有化的方案將：(a) 降低康基醫療的行政、合規及其他上市相關成本；(b) 緩解康基醫療面臨的短期業績指標壓力，使康基醫療能夠專注於長遠戰略決策（例如可能導致短期虧損的長期研發投入及運營升級）；以及(c) 為現有股東提供明確保障，使其能以顯著高於未受干擾股價之溢價，實現於康基醫療之權益變現。綜上所述，要約方認為私有化交易能為全體股東提供即時且最具吸引力價值的戰略選擇，同時可規避不確定市場環境帶來的風險。交易方案概述本次私有化方案設定的股份註銷價格為每股9.25港元，按股權價值計算對公司估值約為14億美元。[1]要約方已明確表示，註銷價格為最終定價且後續不會上調。該註銷價格體現以下考量：較股份於未受干擾日期（即2025年6月30日）在聯交所所報收盤價溢價約21.7%。較股份於截至未受干擾日期（包括該日）止360個交易日在聯交所所報的平均收盤價溢價約47.3%。以及截至未受干擾日期（包括該日）止於聯交所所報之股份價格的過去52週最低收盤價（5.01港幣）溢價約84.6%。此外，在較長的過往期間內，註銷價格超過了股份自2022年以來的最高收盤價（8.66港幣）。本次註銷價格的確定已綜合考量下列因素（包括但不限於），股份於聯交所的近期及歷史交易價格，公司公開披露的財務資訊，及參照近年來香港市場類似私有化交易案例。該方案的實施受限於所有先決條件於2026年1月31日（先決條件最後截止日期）或之前達成，並在2026年4月30日（最後截止日期）之前滿足條件。公司將委任獨立財務顧問（"IFA"）向為方案目的而設立的獨立董事委員會（"獨立董事委員會"）提供意見，以便就方案向股東作出推薦建議。方案的詳情，包括獨立董事委員會的最終推薦意見及獨立財務顧問的意見函，將載入計劃文件，並預期在切實可行的情況下儘快寄發給股東。協議安排會議協議安排會議的具體細節將載於計劃文件，該文件預計將於適當時候寄發予股東。本次交易尚需滿足《聯合》公告所列的多項先決條件及條件，包括但不限於監管批准、股東批准及其他法定合規要求。不可撤銷承諾本公司已獲得一名機構股東作出的不可撤銷承諾，將就該項提案投贊成票。詳情請參閱《聯合公告》。康基醫療已於2025年7月18日上午9時正起於聯交所暫停買賣，以待刊發本公告。公司已向聯交所申請股份自2025年8月13日上午9點起恢復買賣。摩根大通擔任要約方獨家財務顧問關於康基醫療控股有限公司康基醫療控股有限公司創立於2004年，總部位於中國浙江省杭州市，於2020年6月在香港聯合交易所主板上市，股票代碼9997.HK。公司專注于設計、開發、生產和銷售微創外科手術器械及配套耗材(「MISIA」)，秉持著「為醫生提供優質產品和服務，致力於人類健康事業」為使命，通過豐富的產品組合為婦產科、普外科、泌尿外科和胸外科等臨床科室的微創外科手術提供一站式解決方案，並致力於發展為一個立足中國，輻射全球的國際化微創外科手術器械及配套耗材平台。關於Knight Bidco Limited要約人、MidCo 及TopCo均為於開曼群島新註冊成立的有限公司及僅為實施該建議而成立的投資控股公司。於本公告日期，要約人由MidCo全資擁有，而MidCo由TopCo全資擁有。於本公告日期，TopCo由財團成員持有，其中Fortune Spring ZM、Fortune Spring YG、TPG Asia VII、Keyhole、Knight Success、NewQuest V及Al-Rayyan Holding分別持有約25.53%、約14.47%、約24.38%、約5.01%、約5.69%、約4.56%及約20.36%。截至本公告發布之日，除聯合公告中「公司的股權架構」一節所披露外，TPG Asia VII、Keyhole、Knight Success、NewQuest V及Al-Rayyan Holding 均非股東。康基醫療現由鍾鳴先生及其配偶申屠女士共同控制，二人合計持有康基醫療52.98%股份。待私有化完成後，鍾氏夫婦將通過"Fortune Spring ZM"與"Fortune Spring YG"繼續持有要約方最終控股公司（TopCo）40.00%股權，並保持第一大股東地位。更多細節詳見《聯合公告》。各創始人實體均為英屬維爾京群島註冊成立的商業公司。Knight Success為一家於新加坡新註冊成立的有限公司及且為一家投資控股公司。Keyhole為一家於開曼群島註冊成立之獲豁免有限公司及投資控股公司。TPG Asia VII為一家於新加坡註冊成立的有限公司。Knight Success 及Keyhole均由TPG Asia VII全資擁有或控制，而後者由TPG Asia GenPar VII Advisors, Inc.控制，並最終由納斯達克上市的特拉華州公司TPG Inc. 控制。TPG是一家全球領先的另類資產管理公司，成立於1992 年，截至2025年6月30日年管理的資產超過2,690億美元。多年來，TPG一直致力於投資變革、增長與創新，旨在為投資者構建多元化的產品與策略，同時藉由貫徹紀律及卓越的營運管理，提升投資策略與投資組合的整體表現。NewQuest V為一家於新加坡註冊成立的有限公司及投資控股公司。NewQuest V由NewQuest Asia Fund V, L.P. 全資擁有，而後者由NewQuest Asia Fund V GP Ltd.控制，並最終由納斯達克上市的特拉華州公司TPG Inc.控制。NewQuest成立於2011年，是亞洲領先的二級私募股權平台之一，擁有亞洲最有經驗的二級團隊，分佈於五個辦事處。自成立以來，NewQuest 一直專注於與普通合夥人合作，創建定制的解決方案，以滿足私募資產持有人及其利益相關者的流動性和其他戰略需求。從2018年建立的戰略合作夥伴關係開始，NewQuest 於2022 年1月成為TPG的全資附屬公司。Al-Rayyan Holding為一家根據卡塔爾金融中心管理局的規定於2012年在卡塔爾成立的有限責任公司，且為卡塔爾主權財富基金卡塔爾投資局全資擁有的間接附屬公司。成立於2005年的卡塔爾投資局旨在投資和管理國家儲備基金。卡塔爾投資局為全球最大、最活躍的主權財富基金之一。卡塔爾投資局投資於廣泛的資產類別及地區，並與世界各地的領先機構合作，建立具有長期前景的全球化及多元化投資組合。於本公告日期，Al-Rayyan Holding 及其一致行方（與Al-Rayyan Holding 單獨或被視為與該財團一致行事的各方除外）均不持有任何股份。如有垂詢，敬請聯繫：康基醫療控股有限公司要約人傳媒聯絡：皓天財經集團有限公司Angie Li & Jason Lai電話：(852) 6150 8598 / (852) 9798 0715電郵：po@wsfg.hk傳媒聯絡: 博然思維Kay Lau+852 6021 7009Tong Li+86 134 8872 6729電郵：TeamKnight@brunswickgroup.com[1] 以每股9.25港币的注销价格、1,207,994,000股流通股，以及7.85的美元兑港币汇率计算免責聲明：本新聞稿中使用的所有未另行定義的大寫術語，其含義均以2025 年 8 月 12日 發佈的《聯合公告》中的釋義為准。本新聞稿須與《聯合公告》全文一併閱讀，公告副本可在以下鏈接查閱。https://www1.hkexnews.hk/listedco/listconews/sehk/2025/0812/2025081201339_c.pdf Copyright 2025 亞太商訊 via SeaPRwire.com.

香港，2025年8月12日 - (亞太商訊 via SeaPRwire.com) - 五礦資源有限公司（「MMG」；股份代號：1208）今日發佈二零二五年中期業績，公司除稅後淨利潤達566.3百萬美元，較二零二四年上半年的除稅後淨利潤79.5百萬美元增長逾600%。這一強勁利潤提升主要得益於旗下三座銅礦的銅產量均有所增長，銅、金、銀、鋅的市場價格上揚，以及Las Bambas因銅產量提升而實現單位成本下降。MMG行政總裁趙晶表示：「今年上半年，MMG的業務實現了卓越的經營和財務表現。此成果充分展現出公司資產組合的優勢、團隊的卓越能力以及對戰略規劃的堅定執行力。」值得關注的是，二零二五年上半年，MMG的安全績效有所改善，每百萬工作小時可記錄總工傷事故頻率（TRIF）為1.81，低於二零二四年全年的2.06。二零二五年上半年具有能量交換的重大事件頻率（SEEEF）為每百萬工作小時0.78，與二零二四年持平。運營方面，公司旗下三座銅礦山的銅銷量與產量均顯著提升，其中Las Bambas表現強勁，Khoemacau和Kinsevere亦處於爬坡階段。澳大利亞兩座礦山雖面臨天氣影響、設備可靠性以及採礦順序導致的品位下降等挑戰，鋅產量仍保持穩定。要點：上半年的EBITDA及EBIT均創下歷史新高，其中EBITDA達1,539.9百萬美元，較二零二四年上半年增長98%，而EBIT總計1,058.8百萬美元，較去年同期增長240%。除稅後淨利潤達566.3百萬美元，包括本公司權益持有人應佔利潤340.0百萬美元。經營活動現金流淨額較二零二四年上半年增長130%，總額達1,185.0百萬美元。這主要受銅銷售量增加及商品價格上漲推動。資產負債持續改善，自Las Bambas收購以來，債務淨額及槓桿率均創下歷史新低。其中，債務淨額自二零二四年底以來減少903.3百萬美元，主要得益於強勁的運營現金流及提前償還Khoemacau合營公司集團500百萬美元的貸款。二零二五年上半年，槓桿率從41%下降至33%。二零二五年上半年，應付銅銷售總量達237,651噸，創二零一八年以来歷史新高。Las Bambas二零二五年上半年銅精礦含銅的產量達210,637噸，較二零二四年同期增長67%。EBITDA創下歷史新高，達1,310.5百萬美元，較二零二四年上半年增長122%。趙晶補充道：「MMG的資產負債表達至十年來最穩健水平--受惠於盈利提升和現金流創造帶動的債務削減。我們躋身全球十大銅生產商的目標觸手可及，透過卓越的運營表現、審慎的資本分配，以及對負責任採礦的持續承諾，我們已為實現這一目標奠定良好基礎。」二零二五年的生產指引維持不變，銅總產量最高可達522,000噸，鋅產量最高可達240,000噸。如果運營環境穩定且無外部干擾，Las Bambas今年有望實現高達400,000噸的銅產量。MMG正致力達成成本目標，Las Bambas和Rosebery已下調C1成本區間，以反映副產品收益改善及強勁的市場條件。本公司正努力完成近期對巴西鎳業的收購，並對公司的長期資產組合及增長前景充滿信心。MMG將持續推動運營所在社區的發展，促進當地經濟與就業，並為全球可持續未來供應所需的關鍵礦物。點擊查看完整的中期業績報告，觀看行政總裁致辭視頻以及下載公司圖片。關於MMGMMG成立於二零零九年，其願景是為低碳未來打造國際領先的礦業公司。公司總部位於澳大利亞墨爾本和中國北京，並在香港聯合交易所上市（聯交所：1208）。MMG的资产組合涵蓋銅、鋅和鈷的生產，並即將拓展至鎳領域。這些金屬資源對全球脫碳和電氣化目標的實現至關重要。目前，公司的運營業務分佈澳大利亞、博茨瓦納、剛果民主共和國及拉丁美洲。更多信息請點擊此處。 Copyright 2025 亞太商訊 via SeaPRwire.com.

俄亥俄州西湖, 2025年8月12日 - (亞太商訊 via SeaPRwire.com) - 全球領先的高性能聚合物解決方案配方、研發和製造企業GEON®高性能解決方案公司今日宣布，其位於美國、加拿大、墨西哥和中國的分支機構已獲得Great Place To Work®（GPTW，「最佳職場」）認證。自2021年與GPTW合作以來，GEON一直秉持著文化與可持續發展的願景，力爭每年都獲得這一殊榮。通過 GPTW 認證GEON獲美國、加拿大、墨西哥和中國「最佳職場」認證。GPTW要求員工對自身體驗、職場文化以及領導行為進行量化評估和基準比較，這些因素已被證明能夠帶來市場領先的營收、員工留任率的提升以及創新能力的增強。「我們非常高興能在公司運營的四個國家連續兩年獲得『最佳職場』認可。『最佳職場』的評選是與全球頂尖僱主進行比較的，這證明了我們在追求卓越企業文化的道路上正走在正確的方向上。」GEON首席執行官特蕾西‧加里森（Tracy Garrison）表示，「我們相信，市場上的領導者也必須是職場上的領導者。為此，我們在全球各地的運營中都致力於營造積極的工作文化，同時努力在仍需提升的領域不斷進步。」GEON獲得了79%的員工敬業度評分，比典型公司高出20%以上。在美國、加拿大和中國，GEON的評分較去年有所提升，在墨西哥則保持穩定。美國的調查涵蓋了GEON的所有員工，包括 GEON於2025年1月收購的Foster, LLC 的員工。根據 Great Place To Work research 的研究，在獲得「最佳職場」認證的企業中，求職者找到優秀上司的可能性高出4.5倍。此外，在通過認證的企業工作，員工期待上班的可能性高出93%，並且獲得公平薪酬和公平晉升機會的可能性是普通企業的兩倍。「正如數據所示，獲得 GPTW 認證不僅反映了我們的企業文化，還直接影響了我們留住那些每天都期待來上班的優秀員工的能力。」GEON 首席人力資源官傑羅姆‧貝格里（Jerome Beguerie）表示，「這對我們的客戶以及他們與我們合作的體驗都有直接影響。」關於 GEON 高性能解決方案GEON® 高性能解決方案是聚合物混配解決方案領域的領先創新者，服務於包括建築與基礎設施、消費品、工業、交通運輸以及電力與通訊等在內的廣泛市場。通過收購 Foster, LLC，GEON 進一步增強了在高速增長的醫療保健和醫療器械行業的參與度，並在高度適應性的乙烯基、聚烯烴和工程樹脂技術組合基礎上，拓展了全方位合同製造業務。GEON 在全球擁有約 1,200 名員工和 15 家世界一流的製造工廠，總部位於俄亥俄州西湖市。了解更多資訊，請訪問 http://www.geon.com 。GEON 是 SK Capital Partners 投資組合中的一家公司。關於 SK CapitalSK Capital 是一家具有變革力的私募投資公司，專注於特種材料、配料以及生命科學領域。公司致力於打造具有韌性、可持續性和增長潛力的企業，從而創造可觀的長期價值。SK Capital 力求利用其在行業、營運和投資方面的經驗，尋找機會將企業轉型為具有更高績效、更優戰略定位、更強增長與盈利能力且營運風險更低的組織。截至 2024 年 12 月 31 日，SK Capital 管理的資產總額約為 100 億美元。更多資訊請訪問 http://www.skcapitalpartners.com 。聯絡資訊Renita AndersonVice President, Marketing & Business Developmentrenita.anderson@geon.com678-772-8953來源: GEON Performance Solutions Copyright 2025 亞太商訊 via SeaPRwire.com.

香港，2025年8月12日 - (亞太商訊 via SeaPRwire.com) - 中國利郎有限公司（「中國利郎」或「本公司」，及其附屬公司，統稱「集團」；股份編號：1234）今天公佈其截至二零二五年六月三十日止六個月中期業績。中國利郎主席兼非執行董事王冬星先生說：「二零二五年上半年，國際貿易環境更趨嚴峻復雜。期內，內地消費逐步復甦，但消費者對非必需品的支出仍然謹慎。中國利郎通過差異化品牌矩陣深耕男裝市場，通過精準的產品定位與渠道策略，鎖定目標客群，推出多款『利郎LILANZ』及『利郎LESS IS MORE』品牌產品，滿足消費市場需求。此外，集團積極佈局全域營銷，加強利郎品牌的知名度，提升線上線下渠道銷售效益，以推動整體銷售，提升營運效益。 」截至二零二五年六月三十日止上半年，集團收入同比增加7.9%至人民幣17.3億元。其中，輕商務及其他系列收入大幅上升31.8%，主要由於輕商務在門店和新零售表現良好的帶動。主系列收入輕微下跌0.2%，主要由於集團在山東與重慶推進DTC業務模式帶來的一次性收入扣減所致。毛利率為50.2%，同比上升0.2個百分點，主要由於直營銷售佔比上升提高了平均單價所致。期內權益股東應佔利潤為人民幣2.4億元（二零二四年上半年：人民幣2.8億元），權益股東應佔利潤率為14.0%（二零二四年上半年：17.5%），每股盈利為人民幣20.2分。期內集團保持財政穩健，現金流充足。董事會建議派發中期股息每股11港仙（二零二四年上半年：13港仙）及特別中期股息每股5港仙（二零二四年上半年：5港仙），繼續維持穩定的派息比率。集團積極推進戰略轉型，並落實「多品牌、國際化」發展策略，實現業務持續擴張。「利郎LILANZ」主系列繼續鞏固在傳統男裝市場的競爭優勢，成功提升品牌知名度和擴大市場份額。主系列於去年完成東北地區及江蘇省的分銷及代銷權回購轉制，並於期內向山東全省和重慶市一級分銷商回購經營權，以DTC模式轉型。針對較年輕消費者的「利郎LESS IS MORE」輕商務系列繼續以全直營模式經營。輕商務新增門店主要集中在西南及中南地區。截至二零二五年六月三十日止，主系列門店共2,443家，輕商務門店331家。期內，集團繼續致力優化銷售渠道，按計劃在優質地段開設購物中心店及奧特萊斯店，及通過科技感的視覺設計和年輕化的空間佈局，將「簡約不簡單」的品牌理念具象化呈現，以提升品牌形象及推動銷售。於二零二五年六月三十日，購物商場店增加至957家（二零二四年十二月三十一日933家）；奧特萊斯店則增加至121家（二零二四年十二月三十一日：103家），共有2,774家零售店。集團新零售業務完成戰略轉型，從過往的庫存清理渠道升級為主力新品銷售平台，於期內收入錄得24.6%的顯著增長。集團持續深耕天貓、京東、抖音等成熟銷售平台的同時，拓展了拼多多、微信視頻號、得物等新興渠道，形成多元化線上銷售網絡。集團同時利用小紅書、微博等社交平台，持續輸出高品質內容，強化內容電商佈局，從而深化與消費者的情感聯結，並擴展新的業務機遇。集團「多品牌、國際化」發展戰略方面，萬星威「MUNSINGWEAR」上半年完成交易交割，計劃於下半年開設首批實體店。而集團在馬來西亞組開設首家門店的計劃順利落實，並於五月份試業，實現海外拓展的成功一步。在產品研發及品牌營銷方面，集團致力在面料、工藝和技術上取得突破，實現全產業鏈自主研發，加強品牌的核心競爭優勢。期內，集團創新研發的持久白免燙襯衫、拒水羽絨3.0及耐洗POLO衫在抗皺、快乾、耐洗等功能上取得多項認可，成功帶動銷售增長。為進一步深化品牌年輕化戰略，集團於期內借助明星影響力、文化IP聯動及沉浸式場景營銷，觸達各線城市及不同年齡層消費者。展望二零二五年下半年，縱然中國消費市場發展仍然存在不同挑戰，中國利郎作為行業的領先者，將繼續發揮自身優勢，因應消費市場變化和科技創新發展，推動變革轉型，提升品牌影響力，實現銷售及盈利持續增長。集團在下半年將繼續深化轉型，主系列將持續在東北地區、江蘇省、山東省和重慶市發揮DTC模式的經營優勢，以實現穩健擴張。同時，集團將根據各市場的具體情況適度擴大規模，進一步提升營運表現。針對全直營模式經營的輕商務系列，集團將著力加強發展基礎，維持目前高速發展的勢頭。集團預期DTC模式於下半年充分釋放潛力，為整體銷售增長作出貢獻。另一方面，集團繼續利用銷售渠道改革的優勢，聚焦省會城市及地級市優質購物中心的核心位置開店，並關閉低效店舖，以提升門店效率；同時亦會審慎佈局奧特萊斯店，增加門店數量以加快清理庫存。二零二五年全年淨開店目標為50至100家門店。為實現線上線下同步發展，集團將致力推進新零售業務發展，繼續善用各個平台，以瞄準年輕客戶群並加強品牌滲透。透過多維度增加品牌曝光，目標新貨品銷售佔電商銷售總金額的比重能提高至80%。同時，集團會通過智慧物流園區的持續升級，進一步優化供應鏈回應速度，滿足消費者需求。集團目標於二零二五年實現新零售業務收入增長20%或以上，整體銷售增長目標不少於10%。憑藉在國內的堅實基礎，集團有信心加速實現「多品牌、國際化」發展策略。萬星威「MUNSINGWEAR」作為多品牌策略的重點項目，下半年會繼續聚焦產品開發，滿足新中產階級對個性化、功能性及可持續時尚的需求。海外業務方面，集團下半年將在馬來西亞開設更多門店，進一步開拓馬來西亞的市場，並同時將積極部署把業務計劃擴大至東南亞其他市場。同時，集團將通過與跨界IP的合作，提升品牌知名度。結合精準的社交媒體行銷和會員計劃，集團將進一步增強與消費者的互動，提升顧客黏性，提升市場份額。王冬星主席總結說：「縱然中國消費市場發展仍然充滿挑戰，但中國政府實施多項提振消費措施，集團對零售市道審慎樂觀。『利郎LILANZ』主系列及『利郎LESS IS MORE』輕商務系列實現創新轉型後，各自定位更為清晰，有利集團從產品開發設計、營銷推廣和銷售方面，做到更精準更高效，成為集團長遠增長動力。另一方面，作為可持續發展的堅定踐行者，集團將ESG理念深度融入企業戰略，持續推動綠色創新與社會共贏。集團於期內首次發佈獨立編制的ESG報告《共創美好生活》，並正式成立ESG管理委員會，將ESG治理納入戰略規劃和核心價值觀中，展現集團對長期價值的承諾。期內，利郎的MSCI ESG評級升至BB，躋身國內男裝行業前列。未來，集團將繼續鞏固在國內男裝行業的領導地位，通過靈活的市場策略和持續創新，實現可持續增長，為股東、員工及客戶創造更大價值。」關於中國利郎中國利郎是中國領先的男裝企業之一。作為一家綜合時裝企業，集團設計、採購、生產並以品牌「利郎LILANZ」及「利郎LESS IS MORE」銷售優質男士商務及休閒服裝。其產品主要於遍佈中國31個省、自治區及直轄市的廣闊零售及分銷網絡銷售。 Copyright 2025 亞太商訊 via SeaPRwire.com.

伊利諾州羅密維爾, 2025年8月13日 - (亞太商訊 via SeaPRwire.com) - 作為高性能材料分銷領域的領導者，Formerra 已與 Syensqo 簽署協議，負責在北美地區分銷其 Solef® 聚偏二氟乙烯（PVDF）材料。該協議擴大了這種關鍵材料的供應範圍，該材料以兼具耐化學性與柔韌性而聞名。Solef® PVDF 加入了 Formerra 日益壯大的高性能材料產品組合，旨在推動產品開發與創新。「透過這項新協議，Formerra 將能夠為多個市場的客戶提供所需材料，以滿足嚴苛的應用需求。」Formerra 業務開發經理 Bob Long 表示：「此外，這也進一步強化了我們的承諾，即為在複雜的性能與法規挑戰中前行的客戶，提供無與倫比的供應渠道、應用支援以及先進材料。」PVDF 因其優異的耐化學性與耐熱性，被定位於性能金字塔的頂端附近。其固有的柔韌性，更進一步提升了其在化學加工、醫療保健及汽車等行業嚴苛應用中的適用性。其主要特性*包括：耐熱性：可在高達 150 °C（302 °F）的環境中持續使用，於室溫下可承受高達 139 bar（2,017 psi）的爆破壓力化學純度：具超純水耐受性，符合半導體產業 SEMI F-57 規範強度與柔韌性的平衡：抗拉屈服強度可達 55 MPa（8,000 psi），斷裂伸長率可達 100%「我們選擇 Formerra 作為 Solef® PVDF 在北美的經銷合作夥伴，是基於他們在技術與商業領域的廣泛觸及能力。」Syensqo 特用高分子公司美洲區銷售總監（通路合作夥伴、經銷與數位銷售）Rose Catherin 表示：「他們對卓越的承諾，以及在關鍵市場的長期耕耘，使其成為擴大 Solef® PVDF 供應與應用的理想夥伴。」*以 TDS 測量標題：Formerra 成為 Syensqo Solef® PVDF 的北美區經銷商重點資訊：Formerra 是 Syensqo Solef® PVDF 在北美的授權經銷商。該協議涵蓋對多元產業高性能應用的支援。PVDF 具備優異的耐化學性、熱穩定性與柔韌性。Formerra 提供技術指導與供應鏈專業知識，協助材料選擇與應用開發。關於 FormerraFormerra 是領先的工程材料分銷商，將全球頂級聚合物與特種材料製造商與醫療保健、消費品、工業與移動出行等市場的數千家 OEM 與品牌商緊密連結。憑藉技術與商業專業能力，Formerra 提供獨特的產品組合深度、強大的供應鏈實力、深厚的產業知識、卓越的服務、領先的電子商務能力以及創新精神。經驗豐富的 Formerra 團隊協助各行業客戶以全新且更優的方式設計、選擇、加工及開發產品，從而提升性能、生產力、可靠性與永續性。欲了解更多資訊，請造訪 www.formerra.com。媒體聯絡Jackie MorrisFormerra 行銷傳播經理jackie.morris@formerra.com來源: Formerra Copyright 2025 亞太商訊 via SeaPRwire.com.

HONG KONG, Aug 11, 2025 - (ACN Newswire via SeaPRwire.com) - Cryofocus Medtech (Shanghai) Co., Ltd. ("Cryofocus" or the "Company," Stock Code: 6922.HK), a global innovator in minimally invasive interventional cryotherapy, last friday announced its unaudited interim results for the six months ended June 30, 2025. The Company demonstrated robust growth momentum and significant operational optimization during the reporting period, with key financial metrics delivering exceptional performance. Notably, its respiratory intervention product portfolio fueled a substantial revenue surge, marking accelerated commercialization progress.Respiratory Intervention Products Emerge as Core Growth Engine, Highlighting Global Competitive EdgeThe Company recorded revenue of RMB51.1 million for the first half of 2025, a 162.4% increase from RMB19.5 million in the same period of 2024, setting a new historical high. This growth was primarily attributable to the strategic focus on respiratory intervention products entering a harvest phase: The Malignant Stenosis Cryoablation System, approved by China’s National Medical Products Administration (NMPA) in March 2025, and the previously commercialized Cryoadhesion System, experienced rapid sales expansion, becoming the dominant revenue drivers. Additionally, the distribution partnership with Boston Scientific’s China affiliate, BSC International Medical Trading (Shanghai) Co., Ltd. (“BSC”), contributed significant incremental revenue from other respiratory intervention products in mainland China.Of particular significance, the Company’s Asthma Cryoablation System received "Breakthrough Medical Device" designation from the U.S. Food and Drug Administration (FDA) – the first such international recognition for a Chinese enterprise in the respiratory interventional cryotherapy field – laying a foundation for global market expansion.Cryofocus has established a highly competitive respiratory intervention portfolio addressing critical indications, including malignant stenosis, benign stenosis, asthma, chronic obstructive pulmonary disease (COPD), peri-pulmonary nodules, chronic cough, and airway tuberculosis. Among these: The Malignant Stenosis Cryoablation System has been successfully commercialized in China; systems for asthma and COPD are in confirmatory clinical trials with expected approvals in 2026; products for cough, tuberculosis, and peri-pulmonary nodules are in various R&D stages; and the Cryoadhesion System (including disposable and re-sterilizable cryoprobes) is approved and marketed. These innovations mainly stem from Cryofocus’s two core technology platforms: unique liquid nitrogen-based cryoablation technology (utilizing liquid nitrogen as the cryogenic energy source) and advanced flexible catheter technology. This integrated platform enables deep low-temperature treatment, precise control, and minimally invasive intervention, offering superior therapeutic efficacy and safety while creating significant technological barriers for competitors.Platform Value Multiplies as Multi-Segment Strategy Accelerates CommercializationCryofocus’s core value extends beyond its respiratory pipeline, underpinned by its distinction as an innovative cryotherapy platform enterprise. Leveraging its liquid nitrogen and flexible catheter technologies, the Company has successfully expanded into multiple high-potential therapeutic areas:In the vascular intervention segment: The Atrial Fibrillation (AF) Cryoablation System (for atrial fibrillation treatment) was commercialized in China in September 2024. The Cryofocus Renal Denervation (Cryo-RDN) System (for hypertension treatment), granted FDA Breakthrough Device designation, is in confirmatory clinical trials. The Pulmonary Hypertension Cryoablation System is currently in the stage of pre-clinical study. The market space for all these related cardiovascular indications is very huge.In the Natural Orifice Transluminal Endoscopic Surgery (NOTES) segment: The respiratory intervention portfolio, as detailed, is rich and leading. The cancer intervention portfolio includes the commercialized Bladder Cryoablation System; the Gastric Cryoablation System and Esophageal Cryospray System are in clinical trials targeting gastric and esophageal cancer markets.In non-cryotherapy products: Commercialized items such as the Pulmonary Nodule Localization Needle and Endoscopic Clip for Anastomosis, alongside pipeline products like the Atrial Fibrillation Pulsed Field Ablation (PFA) System and Anti-Gastroesophageal Reflux System, create complementary synergies.This "one-platform, multi-therapy" model endows Cryofocus with exceptional adaptability for indication expansion and pipeline sustainability. The Company currently boasts a robust portfolio of 23 products and candidates: 14 cryotherapy and 9 non-cryotherapy items, with 11 already commercialized. Such platform-based diversification is rare among single-therapy medical device firms, highlighting substantial long-term growth potential and risk resilience.Strong Financial Performance and Sustained Growth MomentumBeyond the revenue surge driven by respiratory products, Cryofocus’s interim results signal positive ongoing growth. The Company’s technological advantages further translated into financial resilience. Gross profit reached RMB34.3 million for the first half of 2025, up 124.5% year-on-year, with a solid gross profit margin of 67.1%. Enhanced R&D efficiency led to significantly reduced losses. R&D expenses optimized to RMB17.9 million (down 51.9% year-on-year), while the period loss narrowed 51.4% to RMB27.2 million, demonstrating a clear trend toward profitability. Cash reserves increased 40.1% from year-end 2024 to RMB63.7 million, providing a solid foundation for sustained R&D and market expansion.Revenue diversification and quality improved as high-value self-developed products (e.g., Malignant Stenosis Cryoablation System) launched and scaled, complemented by deepening collaboration with BSC. The significant reduction in R&D expenses reflects improved efficiency and reduced consumable needs as products advance, driven by optimized personnel costs and management enhancements. This establishes a sound framework for balancing innovation intensity with cost control.Furthermore, the Company increased investment in sales network development, with selling and distribution expenses rising 174.4% year-on-year to RMB9.2 million, underscoring proactive resource allocation to build marketing teams and promote newly launched products (e.g., Malignant Stenosis Cryoablation System), laying groundwork for future sales scale expansion.Global Peer Benchmark Highlights Valuation PotentialCryofocus’s technological strength in respiratory interventional cryotherapy, particularly in FDA-designated areas like asthma treatment, positions it competitively against global leaders.Benchmarked against Inspire Medical Systems (INSP) (focusing on OSA neurostimulation, differing in indication but similar in respiratory neuro-intervention): Inspire currently holds a market capitalization of US$2.279 billion and a trailing-twelve-month (TTM) P/E ratio of 44.28x. Cryofocus’s Asthma Cryoablation System similarly targets pulmonary vagal nerves via minimally invasive ablation, with an innovative pathway validated by FDA Breakthrough status. Yet, as a diversified platform innovator with a broad pipeline and multiple commercialized products, Cryofocus’s current Hong Kong market valuation (Inspire’s market cap is 12.8x Cryofocus’s) significantly trails Inspire’s.This substantial valuation gap, while influenced by factors such as differing markets (US vs. HK), stages of development (Inspire being profitable and established in the US market), and a single-product focus versus a platform model, nonetheless clearly underscores the significant upside potential in Cryofocus Medtech's current market valuation relative to its technological capabilities, the breadth of its product pipeline, and its potential for globalization breakthroughs. With the advancement of clinical progress for its respiratory intervention products (particularly the Asthma Cryoablation System COPD Cryospray System Peri-Pulmonary Nodule Cryoablation System), the clarification of overseas registration pathways, and the continued high-speed growth in its revenue scale, a market re-rating of its value represents a high-probability event. The current valuation level presents an attractive window of opportunity for investors bullish on the long-term prospects of the minimally-invasive interventional cryotherapy sector and the value inherent in a platform company model.Looking ahead, Cryofocus maintains a clear strategy: rapidly advance clinical development and commercialization of pipeline products; deepen focus on minimally invasive interventional cryotherapy while expanding the portfolio leveraging its core platforms; continuously invest in underlying and supporting technologies; and selectively expand global operations. The Company is steadily transitioning from R&D-driven to a dual-engine model integrating R&D and commercialization, advancing resolutely toward its vision of becoming a "global platform for minimally invasive interventional cryotherapy medical devices." Copyright 2025 ACN Newswire via SeaPRwire.com.

香港, 2025年8月12日 - (亞太商訊 via SeaPRwire.com) - 2025年8月11日，康師傅控股有限公司（0322.HK，以下簡稱「公司」，連同其附屬公司「集團」）發佈2025年上半年業績公告。2025年上半年，本集團敏銳把握發展契機，聚焦核心業務的精細化運營，持續優化成本結構與運營效能，扎實推進高質量發展進程，整體經營表現穩健，關鍵財務指標持續向好。截至2025年6月30日止六個月，集團收益同比下降2.7%至400.92億元人民幣。其中，方便面事業收益為134.65億元人民幣，飲品事業收益為263.59億元人民幣。毛利率同比提高1.9個百分點至34.5%，EBITDA同比增長13.0%至54.51億元人民幣。受毛利率同比提高帶動，本公司股東應佔溢利同比提高20.5% 至22.71 億人民幣。財務摘要 截至6月30日止6個月 人民幣千元2025年2024年變動收益40,092,16341,201,208↓ 2.7%毛利率（%）34.5%32.6%↑ 1.9個百分點集團毛利13,815,03513,439,915↑ 2.8%扣除利息、稅項、折舊及攤銷前盈利（EBITDA）5,450,6374,824,605↑ 13.0%本期溢利2,688,3042,235,065↑ 20.3%本公司股東應佔溢利2,271,1161,885,310↑ 20.5%本公司股东应佔经调整溢利*2,111,6041,855,310↑ 12.0%每股溢利（人民幣分） 基本40.3033.46↑ 6.84分 攤薄40.2833.46↑ 6.82分於2025年6月30日之銀行存款及現金（含長期定期存款）為人民幣19,491,373千元，相較2024年12月31日增加人民幣3,488,705千元，淨負債與資本比率為-35.0%。* 本公司股東應佔經調整溢利包括除出售附屬公司産生的收益之一次性交易外之所有本公司股東應佔溢利。2025年上半年，中國經濟在結構性挑戰中保持穩健增長態勢。消費市場呈現多元化特徵，消費者在健康需求與休閒享受、個性化追求與大眾化選擇之間尋求平衡，更加注重產品品質、情感共鳴與差異化體驗。消費行為呈現「高頻次、低單量」特點。即時零售業態快速崛起，興趣電商已成為線上流量的核心入口，折扣店與會員店模式加速擴張，全渠道融合與縣域下沉成為新增量。在此背景下，具備敏銳市場洞察力、能夠圍繞健康化、場景化需求創新產品組合，並通過多渠道深度滲透實現用戶觸達與轉化的企業，將更高效地響應市場需求變化，持續強化用戶粘性，實現高質量發展。2025年上半年，方便面事業的毛利結構持續優化。方便面事業收益為134.65億元人民幣，佔集團總收益33.6%。期內因產品升級調價，方便面毛利率同比提高0.7個百分點至27.8%。由於毛利率同比提高帶動，方便面事業2025年上半年的本公司股東應佔溢利同比提高11.9%至9.51億人民幣。期內，面對消費趨勢日益多元化及渠道變革持續加速的外部環境，方便面事業積極應對挑戰，秉持高質量發展理念，通過優化核心品類結構與創新產品組合實現業務持續增長。通過構建多價位的產品矩陣，全面滿足消費者對即食美味的多樣化需求。在品牌營銷方面，依託知名IP合作與明星代言矩陣，有效深化品牌情感價值傳遞，精准觸達年輕消費群體並建立深度共鳴。渠道策略上，重點發力零食量販、會員店等新興渠道，推出差異化場景產品以精准匹配細分市場需求。作為方便面行業航天技術應用的開拓者，率先將航天技術與標準引入制面工藝，「天選好面」以航天標準重塑品質內核，為消費者帶來值得信賴的卓越體驗。飲品事業堅定貫徹「穩增長調結構」雙輪驅動發展戰略。飲品事業整體收益為263.59億人民幣，佔集團總收益65.7%。期內，因原材料有利與管理效能提升，飲品毛利率同比提高2.5個百分點至37.7%。由於毛利率同比提高，飲品事業2025年上半年本公司股東應佔溢利同比提高19.7%至13.35億人民幣。期內，通過持續優化產品口味創新、包裝升級及工藝改進，不斷提升產品競爭力，夯實核心品類領先地位。同時深化消費者洞察，精准把握市場需求，依託強勁研發實力加速創新產品升級。在營運策略上，積極擁抱渠道多元化趨勢，構建全域營銷體系，強化線上線下協同效能。數字化轉型方面，以 AI 技術為核心加速戰略升級，構建企業級數據中台，賦能業務決策與運營效率，持續鞏固和擴大市場競爭優勢。康師傅行政總裁陳應讓先生表示：「展望2025年下半年，政府將繼續強化促消費擴內需政策組合，居民消費潛力有望得到進一步釋放。在此背景下，本集團堅定貫徹『鞏固、革新、發展』的戰略方針，恪守長期主義發展理念，以消費者需求為立足點，聚焦主營業務深耕細作，致力於實現健康高質量的發展。在產品層面，通過優化產品結構、加大研發投入，構建多層次、高品質的產品矩陣，持續提升產品力與差異化競爭優勢；在品牌建設方面，實施多元化營銷策略，強化與消費者的情感連接，實現品牌聲量與情感價值的雙重提升；在運營管理上，加速數字化轉型進程，重點推進企業級數據中台建設，深化AI技術應用，構建智能運營體系以賦能業務決策；在經營質量方面，持續優化成本結構，提升盈利能力，確保經營態勢穩健發展與業績高質量增長。我們將可持續發展理念融入經營實踐，堅定履行社會責任，敏銳把握市場機遇，致力於實現經濟效益與社會價值的協同發展。我們將與合作夥伴攜手共進，以優質產品服務消費者，以豐厚回報回饋股東，矢志成為政府認可、夥伴信賴、消費者首選的綜合性食品飲料『民族品牌』。」關於康師傅控股有限公司 (0322.HK)康師傅控股有限公司（「本公司」）及其附屬公司（「本集團」）主要在中國從事生產和銷售方便面及飲品。本集團於1992年開始生產方便面，並自1996年起擴大事業至方便食品及飲品；2012年3月，本集團進一步拓展飲料事業範圍，完成與PepsiCo中國飲料事業之戰略聯盟，開始獨家負責制造、灌裝、包裝、銷售及分銷PepsiCo於中國的非酒精飲料。「康師傅」作為中國家喻戶曉的品牌，經過多年的耕耘與積累，深受中國消費者喜愛和支持。如有垂詢，請聯絡：投資者查詢康師傅控股有限公司投資者關係團隊電郵：ir@tingyi.com匯思訊中國有限公司陳敏芝電郵：stephanie.chen@christensencomms.com電話：+852 2117 0861 Copyright 2025 亞太商訊 via SeaPRwire.com.

香港，2025年8月12日 - (亞太商訊 via SeaPRwire.com) - OMS能源技術公司(「OMS能源」或「公司」，股份代號：OMSE)與新加坡國家人工智能編碼治理與技術監管領軍機構Ministry XR Pte Ltd(以下簡稱「Ministry XR」)於8月6日正式簽署諒解備忘錄，以建立深度戰略合作夥伴關系。OMS能源和Minstry XR將依托各自擁有的AI驅動的機器人編碼技術及卓越的工程能力，共同推動傳統能源行業智能化轉型，邁向更高效低成本且具有高度安全性的可持續發展的未來。(左起) OMS能源首席執行官侯明福及Ministry XR首席技術官Andrew Yew此次合作聚焦「智能重塑能源」的長期戰略佈局，旨在通過三大支柱構建完整生態：1.人工智能機器人編碼前沿研發雙方將聯合開發針對能源行業的專屬AI驅動機器人編碼框架，重點突破預測性維護、自動化運營、環境合規監測及安全規程自動化等核心場景。該技術將大幅減少人為操作誤差、消除極端天氣、陡峭地形、有毒氣體空間、偏遠地區等不同環境條件下的人員安全風險、提升能源基礎設施的正常運行時間，為油氣管道、井口系統等關鍵設施的全生命周期監測及維護提供技術保障。2.商業化與市場規模化部署技術落地將從實驗室快速邁向產業端：Ministry XR部將協助OMS能源設計可擴展的商業化路徑，包括開展試點項目、與現有工業系統整合、提供監管合規與認證支持等。雙方計劃打造具備全球競爭力的出口級技術，覆蓋亞太、中東及北非等OMS能源現有業務所在的核心市場，加速能源行業智能化解決方案的普及。3.學術與創新生態協同依托OMS能源與新加坡製造技術研究院(SIMTech)等機構的長期研發合作基礎，OMS能源與Ministry XR將聯合頂尖學術機構共建「人工智能-機器人創新實驗室」，開發專業課程、搭建人才輸送渠道，推動科研成果直接轉化為產業應用，形成「產研用」閉環。共同願景：讓智能與ESG理念成為行業標準OMS能源首席執行官侯明福先生補充道：「OMS近50年深耕油氣工程領域，在6國擁有11個製造基地及600餘名專業團隊，核心產品OCTG(油井管材)與SWS(地面井口系統)已銷售至全球超200家優質客戶。此次與Ministry XR的合作，將加速我們的業務拓展至『油田及城市水道全生命周期管道監測維護服務』領域，讓AI與機器人技術成為能源行業降本增效、消除環境風險、綠色發展的核心引擎。油氣行業的作業風險高，安全作業至關重要。AI人工智能機器人技術將顯著降低油氣項目日常作業的風險，尤其是在極端氣候和惡劣地理環境下，可進一步確保作業的可持續性、安全性和高效性。」Ministry XR首席技術官Andrew Yew在簽約儀式上表示：「作為新加坡國家人工智能編碼治理與技術監管的領軍機構，我們將全程參與OMS項目生命周期，從技術選型到戰略落地提供全維度支持。此次合作不僅是對能源行業數字化轉型的響應，更是引領全球能源技術標準的主動佈局。」關於OMS能源技術公司OMS能源技術公司是上游油氣開發領域的資深工程技術企業，專註於設計、認證和製造精密工程系統，核心產品包括油井管材(OCTG)、地面井口系統(SWS)及專用連接器等，同時提供高級螺紋加工、管道檢測維護等增值服務。公司業務覆蓋亞太、中東及北非、西非等地區，憑借ISO 9001、API Q1等權威認證及穩健財務表現，成為全球能源行業信賴的合作夥伴。關於Ministry XRMinistry XR是新加坡國家人工智能編碼治理與技術監管的領軍機構，致力於推動AI與機器人技術的規範應用及產業落地，在技術標準製定、全球前沿技術評估等領域具備深厚積累，為關鍵行業數字化轉型提供戰略指導與技術支持。此新聞稿由Messis Global代OMS能源技術公司發布投資者及媒體查詢電郵：pr@messis-global.com Copyright 2025 亞太商訊 via SeaPRwire.com.

HONG KONG, Aug 11, 2025 - (ACN Newswire via SeaPRwire.com) - The Hong Kong Trade Development Council (HKTDC) organised a delegation to Hanoi, Vietnam from 5 to 7 August to promote Hong Kong’s professional services and assist Hong Kong professional service providers in exploring business opportunities.As Hong Kong's sixth-largest trading partner and the second largest among ASEAN members, Vietnam has steadily strengthened trade and economic relations with Hong Kong. The delegation aims at further deepening bilateral business ties and introducing Hong Kong's professional services to local businesses there.The delegation, co-led by Patrick Lau, HKTDC Deputy Executive Director, and Rimsky Yuen, Chairman of the HKTDC Professional Services Committee Advisory Committee, comprised 19 Hong Kong professionals from various sectors, including accounting, legal, consulting and corporate services.During the visit, delegate Tim Koo, Director, Normsun Advisory Services Limited, signed a memorandum of understanding (MoU) with the Institute of Trade and Economics of Vietnam, reflecting a commitment by both sides to strengthen cooperation.Meetings with Vietnam’s government bodies, industry associations and large local enterprises – such as the Foreign Investment Agency under Ministry of Finance, Kinh Bac Group, National Innovation Center, The Association of Chartered Certified Accountants Vietnam, The Vietnam Association of Certified Public Accountants, Vietnam Bank’s Association, Vietnam International Arbitration Centre and VMO Holdings – provided a plethora of opportunities for Hong Kong delegates to explore cooperation opportunities with their Vietnamese counterparts. One of the mission highlights, which was the lunch seminar co-hosted by the HKTDC and Vietnam Chamber of Commerce and Industry, successfully promoted Hong Kong’s role as a regional centre for professional services and risk management. Attracting over 120 Vietnamese business representatives and professionals, it encouraged local enterprises to collaborate with Hong Kong service providers when expanding their business or managing risks.At the lunch seminar, Dr Lau said: "This mission is a part of the HKTDC's new Hong Kong Professionals Plus campaign. We hope to tell the stories of Hong Kong through business delegations and visits as well as promote the strengths of Hong Kong's professional services sector, while at the same time assist them to better understand the latest developments in the ASEAN markets and to seize business opportunities."Mr Yuen stated: "As an international financial centre and a regional hub for professional services, Hong Kong possesses top-tier talents offering world-class legal, financial and consulting services. With extensive experience in facilitating cross-border investments and fund-raising over the years, Hong Kong can meet the development needs of Vietnamese enterprises and assist investors from other countries in seizing opportunities in Vietnam."The HKTDC regularly organises business missions across industries. It will continue to conduct outreach activities to promote the advantages of Hong Kong’s professional services, while helping service providers seize more overseas collaboration opportunities.Photo Download: http://bit.ly/4fu1HBjPatrick Lau, HKTDC Deputy Executive Director (third left, front row), and Rimsky Yuen, Chairman of the HKTDC Professional Services Committee Advisory Committee (fourth left, front row), co-led a delegation to Hanoi, Vietnam, comprising 19 delegates from the professional services sectorTim Koo, Director, Normsun Advisory Services Limited (second right) signed a memorandum of understanding (MoU) with the Institute of Trade and Economics of VietnamA highlight of the mission was the lunch seminar co-hosted by the HKTDC and Vietnam Chamber of Commerce and Industry, which attracted over 120 business representatives and professionals from VietnamPatrick Lau, HKTDC Deputy Executive Director, delivered remarks at the lunch seminarRimsky Yuen, Chairman of the HKTDC Professional Services Committee Advisory Committee, spoke at the lunch seminarMedia enquiriesHKTDC’s Communication & Public Affairs Department:Johnny Tsui Tel: (852) 2584 4395 Email: johnny.cy.tsui@hktdc.orgAbout HKTDCThe Hong Kong Trade Development Council (HKTDC) is a statutory body established in 1966 to promote, assist and develop Hong Kong's trade. With over 50 offices globally, including 13 in Mainland China, the HKTDC promotes Hong Kong as a two-way global investment and business hub. The HKTDC organises international exhibitions, conferences and business missions to create business opportunities for companies, particularly small and medium-sized enterprises (SMEs), in the mainland and international markets. The HKTDC also provides up-to-date market insights and product information via research reports and digital news channels. For more information, please visit: www.hktdc.com/aboutus. Copyright 2025 ACN Newswire via SeaPRwire.com.

HONG KONG, Aug 12, 2025 - (ACN Newswire via SeaPRwire.com) - OMS Energy Technologies Inc. ("OMS Energy" or the "Company", stock code: OMSE) and Ministry XR ("Ministry XR"), a leading national institution for AI code governance and technical supervision in Singapore, officially signed a memorandum of understanding on 6 August 2025 to establish an in-depth strategic partnership between two parties. Leveraging AI-driven robotic coding technology and the cutting-edge engineering capabilities possessed by each other, OMS Energy and Ministry XR will jointly promote the intelligent transformation of the traditional energy industry, moving towards a more sustainable development future with high efficiency, low cost and high security.(Left) Mr. How Meng Hock, Chief Executive Officer of OMS Energy and Mr. Andrew Yew, Chief Technology Officer of Ministry XRThis cooperation focuses on the long-term strategic layout of "intelligently reshaping energy", aiming to build a complete ecosystem through three pillars:1.Frontier R&D in AI Robotic CodingOMS Energy and Ministry XR will jointly develop an exclusive AI-driven robotic coding framework tailored for the energy industry, with a focus on breaking through core scenarios such as predictive maintenance, autonomous operation, environmental compliance monitoring, and automation of safety protocols. This technology will significantly reduce human operation errors, eliminate personnel safety risks under different environmental conditions like extreme weather, steep terrain, a space filled with poisonous gas, remote area, etc, improve the uptime of energy infrastructure, and provide technical guarantees for the full-lifecycle inspection and maintenance of critical facilities such as oil and gas pipelines and wellhead systems.2.Commercialization and Large-Scale Market DeploymentTechnology implementation will quickly move from the laboratory to the industrial end: Ministry XR will assist OMS Energy in designing scalable commercialization pathways, including conducting pilot projects, integrating with existing industrial systems, and providing regulatory compliance and certification support. The two parties plan to develop export-grade technologies with global competitiveness, covering the core markets such as Asia-Pacific, the Middle East, and North Africa where OMS Energy currently operate to accelerate the popularization of intelligent solutions in the energy industry.3.Academic and Innovation Ecosystem CollaborationBuilding on OMS Energy's long-term R&D cooperation with institutions such as the A*Star Singapore Institute of Manufacturing Technology (SIMTech), OMS Energy and Ministry XR will jointly establish an "AI-Robotics Innovation Laboratory" with top academic institutions. They will develop professional courses, establish talent delivery channels, promote the direct transformation of scientific research achievements into industrial applications, and form a closed loop of "industry-research-application".Shared Vision: Let Intelligence and ESG Concepts become Industry StandardsMr. How Meng Hock, Chief Executive Officer of OMS Energy, added: "OMS Energy has been deeply engaged in the oil and gas engineering field for nearly 50 years, with 11 manufacturing bases in 6 countries and a professional team of over 600 people. Our core products, OCTG (Oil Country Tubular Goods) and SWS (Surface Wellhead Systems) have sold to over 200 high-quality customers worldwide. This cooperation with Ministry XR will accelerate our business expansion into a 'full-lifecycle pipeline inspection and maintenance service sector in oilfield and urban water supply and wastewater industry', making AI robotics technology the core engine for cost reduction, efficiency improvement, environmental risk elimination and green development in the energy industry. Safety operation is paramount in the oil and gas industry due to the inherent risks associated with the work. AI robotics technology will significantly reduce the risks involved in daily operations in oil and gas projects, especially in extreme climates and harsh geographical environments, and further ensure the sustainability, safety, and efficiency of operations."Mr. Andrew Yew, Chief Technology Officer of Ministry XR stated at the signing ceremony: "As a leading national institution for AI code governance and technical supervision in Singapore, we will participate in the full-lifecycle of OMS Energy projects, providing full-dimensional support from technology selection to strategic implementation. This cooperation is not only a response to the digital transformation of the energy industry but also a proactive layout to lead global energy technology standards."About OMS Energy Technologies Inc.OMS Energy Technologies Inc. is a seasoned engineering and technology enterprise in the upstream oil and gas development sector, specializing in the design, certification, and manufacturing of precision engineering systems. Its core products include OCTG (Oil Country Tubular Goods), SWS (Surface Wellhead Systems), and specialized connectors, while also providing value-added services such as advanced threading processing and pipeline inspection and maintenance. With business covering regions including Asia-Pacific, the Middle East, North Africa, and West Africa, and backed by authoritative certifications such as ISO 9001 and API Q1 as well as stable financial performance, the Company has become a trusted partner in the global energy industry.About Ministry XRMinistry XR is a leading national institution for AI code governance and technical supervision in Singapore, dedicated to promoting the standardized application and industrial implementation of AI and robotics technologies. It has profound industry know-how in fields such as technical standard formulation and evaluation of global cutting-edge technologies, providing strategic guidance and technical support for the digital transformation of key industries.This press release is issued by Messis Global on behalf of OMS Energy Technologies Inc.For investor and media inquiriesEmail: pr@messis-global.com Copyright 2025 ACN Newswire via SeaPRwire.com.

迪拜，阿聯酋, 2025年8月11日 - (亞太商訊 via SeaPRwire.com) - 作為網絡智能與網絡安全創新領域的新興領導者，31 Concept（簡稱31C）今日宣佈，將在2025年新加坡ISS Asia大會上首次發佈其申請專利的新技術。該突破性成果由公司旗下的31 Concept研究實驗室獨立研發完成，標誌著這家初創企業在僅僅七個月的高強度研發後正式走出隱秘階段，迎來重要里程碑。31 Concept創新成果獲專利31 Concept研究實驗室是公司創新的核心引擎，匯聚了深度封包檢測、人工智慧驅動分析、網路安全及先進網路技術領域的世界級專家。實驗室團隊在電信、軍事及國家基礎設施等專案中累積了數十年的綜合經驗，立足於應用研究與實際部署的交匯點，致力於提供可大規模解決現實挑戰的方案。「我們的申請專利技術，正是源於研究實驗室獨特的專業能力與不懈的進取精神。」31C首席執行官兼聯合創始人 Misha Hanin 表示，「我們在創紀錄的時間內完成了研發，同時毫不妥協於品質與創新。這只是我們計劃推向市場的一系列突破中的第一步。」ISS Asia被公認為全球情報、安全及執法技術領域最重要的專業會議之一，將為此次首發提供全球舞臺。該盛會吸引了來自政府、電信及私營行業的領軍人物，是31C首次公開亮相的理想場所。「31 Concept研究實驗室以極高的速度將一個概念轉化為正在申請專利的現實，充分體現了我們團隊的實力與流程的高效性。」31C首席技術官鮑里斯·海斯曼（Boriss Heismann）補充道，「這項技術旨在解決網路可視性、安全性及性能方面最迫切的需求，而且是以業界前所未有的方式實現的。」在2025年ISS Asia大會上，31C將重點展示這一全新平台的功能，詳細介紹其專利申請中的核心要素，並公佈目前正在研發中的後續創新路線圖。關於31C31 Concept是一家專注於為電信營運商、政府及受監管行業打造新一代數據智能平台的科技公司。其核心研發部門——31 Concept研究實驗室，致力於在網路智能、網路安全及人工智慧驅動分析領域研發突破性技術。聯絡資訊Misha HaninCEOmisha.hanin@31c.io來源: 31 Concept相關圖片 Copyright 2025 亞太商訊 via SeaPRwire.com.

TransNusa Increases Flight Options For Two Routes From ManadoPT TransNusa Aviation Mandiri converts two chartered flights from Manado to scheduled commercial flightsTickets sale for Manado to Shanghai and Manado to Shenzhen started on July 29, 2025TransNusa continuously expands international route and starts strengthening Manado base in IndonesiaJAKARTA, Aug 11, 2025 - (ACN Newswire via SeaPRwire.com) - FOCUSING on organic growth, TransNusa converts two charter flight routes between Manado and Shanghai as well as Manado and Shenzhen to scheduled commercial routes, starting 8 September and 2 October, respectively.TransNusa Group Chief Executive Officer, Datuk Bernard Francis said while the Manado-Shenzhen scheduled commercial flight is direct, the Manado-Shanghai flight plan has a stop-over of between 30 to 35 minutes at the Clark International Airport.“Our main priority and focus is to create new exciting routes for our passengers and offer seamless and fast travels, whether through direct routes or transits routes.” Datuk Francis said, explaining that the Manado-Clark-Shenzhen route is very popular among tourists.“With the launch of these new commercial routes, we hope to provide tourists from Manado and China additional options to travel,” Datuk Francis said, adding that TransNusa will also provide its passengers with options to visit other major tourist destinations from Manado, such as Bali, also known as Indonesia’s Island of Gods.Details of the new RoutesFrom October 2, TransNusa will be operating three flights a week from Manado’s Sam Ratulangi International Airport to Shenzhen Bao’an International Airport. The TransNusa flight, 8B 175, will depart Manado at 21.10pm and arrive at the Shenzhen Bao’an International Airport at 01.00am while TransNusa flight, 8B 176, will depart Shenzhen Bao’an International Airport at 02.00am and arrive in Manado at 05.50am.TransNusa will be operating the Manado-Shenzhen route three times weekly. The Manado-Shenzhen route scheduled commercial flights are on Tuesday, Thursday and Saturday while the Shenzhen-Manado route scheduled commercial flights will be on Wednesday, Friday and Sunday.TransNusa’s scheduled Manado-Shenzhen flight ticket price starts from as low as IDR3.499.000, CNY1.525 and USD226 while it’s schedule flight from Manado to Shanghai ticket price starts from as low as IDR3.988.000, CNY1.688 and USD257. TransNusa tickets are available for purchase at transnusa.co.id and all other main online travel agent platforms worldwide.Meanwhile, the TransNusa flight, 8B 101, from Manado will depart at 14.00pm and arrive at the Clark International Airport at 16.40pm. The flight will depart Clark International Airport at 17.15pm and arrive at the Shanghai Pudong International Airport at 20.55pm. The flight, 8B 102, will depart the Shanghai Pudong International Airport at 23.05pm and arrive at Clark International Airport at 02.30am. The TransNusa 8B 102, will depart Clark International Airport at 03.00am and arrive at Manado’s Sam Ratulangi International Airport at 05.30am.Datuk Bernard said that TransNusa will operate the six hours 50 minutes scheduled commercial flight route 3 times week. TransNusa’s scheduled commercial flight from Manado will depart on Monday, Wednesday, and Friday.For both the newly introduced scheduled commercial flights, Datuk Bernard said TransNusa will be utilizing its C909 jet airliner, which has only 95 seats, to ensure that passengers travel with comfort.Datuk Bernard Francis…TransNusa offers new flight options for its passengersBrief History On TransNusaTransNusa, which had to close business due to the Covid-19 pandemic was injected with new shareholders and management team in 2022. The airline opened its doors for business in October and within six months, in April 2023, launched its first international flight from Jakarta to Kuala Lumpur, Malaysia.After which, under the new leadership of Datuk Francis, and the new management team, the airline successfully launched three more new international routes by the end of 2023. In 2024, the airline continued growing its international and domestic route and at the same time recording historical firsts that also became a significant industry first for the Indonesian aviation industry. Since April 2023, TransNusa has been making headlines in Malaysia, Singapore, China and around the world with news of being the first airline in Indonesia and the world to develop and introduce a new domestic route connecting Bali and diving haven, Manado. TransNusa also became the second Indonesian airline to receive approval to fly to China and provided Indonesians with more pricing and route options to China.TransNusa’s aggressive international growth strategy combined with its domestic business operations approach has enabled the airline to be the fastest growing airline in South East Asia.About TransNusaTransNusa Airline, is a Premium Service Carrier. After the take-over, in February 2024, the airline rebranded itself from being a Low-Cost Carrier to a Premium Service Carrier in line with its upgraded aircrafts that offers better comfort as well as based on the flexibility and quality of the services offered.TransNusa, which received its AOC certification on 9th September 2022, launch its first three A320 operations on 6th October, 14th October and 12th December, 2022. In 2023, TransNusa introduced a new business model making it the first Premium Service Carrier in the Asia Pacific region. TransNusa introduced its first international flight on 14th April, 2023. The airline is currently has bases in Jakarta, Bali and Manado.The airline currently flies from Jakarta to Yogyakarta, Bali, Kuala Lumpur, Malaysia, Subang, Malaysia and Guangzhou, China. It also flies from Bali to Jakarta and Manado. TransNusa will be launching its scheduled Bali to Perth route on March 20th and its Bali to Guangzhou route on April13th. TransNusa made history when it became the second Indonesian airline to fly to China and the first Indonesian airline to launch a Premium Service Carrier business model.Passengers can book their flights on the TransNusa website (www.transnusa.co.id), through authorized travel agents in Singapore, Malaysia and Indonesia, or by contacting the airline's customer service centre at, +62216310888. For the Singaporean market, passengers can contact TransNusa’s General Sales Agent, Chariot Travels Pte Ltd, at +65 86602719 for assistance.TransNusa’s Primary Media Contact:Trina Thomas Rajtrina@myqaseh.org+60124992672 (watsapp) Copyright 2025 ACN Newswire via SeaPRwire.com.

DUBAI, Aug 11, 2025 - (ACN Newswire via SeaPRwire.com) - 31 Concept (31C), an emerging leader in network intelligence and cybersecurity innovation, today announced it will unveil its first patent-pending technology at ISS Asia 2025 in Singapore. The breakthrough, developed entirely within the company's 31 Concept Research Lab, marks a major milestone for the startup, which is stepping out of stealth mode after just seven months of intense development.31 Concept's Innovation PatentedThe 31 Concept Research Lab serves as the company's innovation engine, uniting world-class experts in deep packet inspection, AI-driven analytics, cybersecurity, and advanced networking. With decades of combined experience from projects spanning telecom, military, and national infrastructure, the lab's team operates at the intersection of applied research and practical deployment, delivering solutions designed to solve real-world challenges at scale."Our patent-pending technology is the direct result of the unique expertise and relentless drive inside our Research Lab," said Misha Hanin, CEO and Co-Founder of 31C. "We built this in record time without compromising on quality or innovation. This is just the first step in a series of breakthroughs we intend to bring to the market."ISS Asia, recognized as one of the most important professional conferences in the world for intelligence, security, and law enforcement technologies, will provide the global stage for the debut. The event draws leaders from government, telecom, and private industry, making it the perfect venue for 31C's first public presentation."The speed at which the 31 Concept Research Lab turned a concept into a patent-pending reality shows the strength of our people and our process," added Boriss Heismann, CTO of 31C. "This is technology designed to address the most pressing needs in network visibility, security, and performance - and to do it in ways the industry has not seen before."The company's presentation at ISS Asia 2025 will highlight the capabilities of the new platform, detail the patent-pending elements, and outline the roadmap for further innovations currently in development.About 31C31 Concept is a technology company focused on next-generation data intelligence platforms for telecom providers, governments, and regulated industries. Its flagship R&D division, the 31 Concept Research Lab, develops breakthrough technologies in network intelligence, cybersecurity, and AI-driven analytics.Contact InformationMisha HaninCEOmisha.hanin@31c.ioSOURCE: 31 ConceptRelated Images Copyright 2025 ACN Newswire via SeaPRwire.com.

沙烏地阿拉伯利雅得, 2025年8月11日 - (亞太商訊 via SeaPRwire.com) - 沙烏地電力公司（SEC）在2025年第二季及上半年持續展現穩健的財務與營運表現。第二季營收成長24%，達到277億沙烏地里亞爾，毛利上升42%，達到74億里亞爾。營業利潤增加21%，達到68億里亞爾；淨利達到53億里亞爾，較去年同期成長22%。在2025年上半年，沙烏地電力公司（SEC）報告營收成長23%，總額達472億沙烏地里亞爾。毛利上升40%，達102億里亞爾；營業利潤增加20%，達91億里亞爾；淨利較2024年同期成長19%，達63億里亞爾。此強勁財務表現主要受益於受管制資產基礎擴張所帶來的可允許收入增加，以及因應能源需求上升而提升的電力生產收入。上述收益部分被網路擴建、資產增加與負載上升所導致的營運與維護成本上升所抵銷，同時還包括應收帳款撥備增加及其他收入減少的影響。SEC指出，其受管制資產基礎的擴張，反映出輸電與配電網路持續成長，以滿足不斷增加的電力需求、支援再生能源併網，以及推進能源儲存專案。公司同時也持續在數位轉型與營運卓越計畫上進行策略性投資。對業績發表評論時，沙烏地電力公司代理執行長哈立德·賓·薩利姆·阿勒加姆迪工程師表示：「2025年上半年的良好表現，反映了公司在業務組合與資產基礎上的持續成長，這與我們的策略一致，即在全國範圍內提供可靠且安全的電力、提升客戶的服務品質，並推進永續發展與營運卓越。我們致力於進一步強化公司的市場地位，並把握沙烏地阿拉伯能源轉型所帶來的重大機遇，這與『2030願景』的宏大目標相契合——而這一切都得益於我們優秀本國員工的奉獻精神，以及我們為國家服務的堅定承諾。」截至2025年上半年末，併入電網的再生能源裝置容量已超過9.2吉瓦，公司並在比沙、賈贊、海米斯穆塞特及納季蘭四個地點，成功啟用總計8.0吉瓦時的電池儲能系統。沙烏地電力公司目前正開發額外14吉瓦時的儲能容量，預計將於明年投入運行並併入電網，進一步強化電網的可靠性與再生能源的整合能力。為重申在營運全程中落實永續發展並提升其ESG（環境、社會與公司治理）實踐的承諾，SEC於2025年在標普全球（S&P Global）的ESG評級中取得顯著躍升，獲得100分中的65分，較2024年提升30%，較2023年更大幅提升85%。此成就使SEC位居沙烏地阿拉伯所有企業之首，並成為中東與北非能源產業的區域領導者，其表現超越全球公用事業產業平均水準66%，進一步鞏固其在永續績效方面的全球領先地位。2025年上半年，電力需求持續上升，尖峰負載成長3%，達到75.1吉瓦，總用電量增加10%，達到1,605億度。於1446年回曆朝覲季期間，SEC在麥加、麥地那及聖地成功應對創紀錄的尖峰負載，且未發生任何服務中斷，這得益於公司全面動員資源，為朝覲者提供服務並確保其舒適。公司在服務擴展與基礎設施建設方面亦取得重大進展。SEC新增連接約11萬名新用戶，將總用戶數提升至1,140萬。配電網路長度成長6%，超過82.7萬迴路公里；輸電網路與光纖網路則分別成長6%與9%，達到103,800與101,000迴路公里。作為提升服務可靠性與客戶體驗的一部分，SEC持續升級數位基礎設施並自動化配電變電站，並透過光纖網路將其連接至控制中心。配電變電站自動化率已達38.4%，客戶滿意度提升至85.8%，顯示服務品質與溝通成效均有所改善。聯絡資訊Saudi Electricity Company (SEC) Saudi Electricity Company (SEC)Media Relations Departmentalkahrabacare@se.com.saUnified Call Center: 920000222來源: Saudi Electricity Company (SEC) Copyright 2025 亞太商訊 via SeaPRwire.com.

香港，2025年8月11日 - (亞太商訊 via SeaPRwire.com) - 專注於微創介入冷凍治療領域的創新醫療器械公司康灃生物科技（上海）股份有限公司（「康灃生物」或「公司」，股份代號：6922.HK）公布其截至2025年6月30日止六個月的中期業績。報告期內，公司展現出強勁的增長動能與顯著的經營優化，核心財務指標表現亮眼，特別是其呼吸介入產品線實現爆發式增長，標誌着公司商業化進程步入快車道。呼吸介入產品成業績增長核心引擎，全球領先優勢凸顯公告顯示，2025年6月30日止六個月，康灃生物實現收入達人民幣5,111萬元，較2024年同期1,948萬元激增162.4%，創下歷史同期新高。這一增長主要源於公司在呼吸介入領域的戰略性布局迎來收穫期：公司2025年3月獲國家藥監局批准的惡性狹窄冷凍消融系統及此前上市的冷凍粘連治療系統等呼吸介入產品銷量迅猛增長，成為驅動收入增長的絕對主力；同時，公司與國際醫療巨頭波士頓科學的中國附屬公司波科國際醫療貿易（上海）有限公司(「波科」)在其他呼吸介入產品的中國大陸的經銷合作也貢獻了可觀的增量收入。更值得一提的是，公司的哮喘冷凍消融系統獲得美國食品及藥物管理局授予的「突破性醫療器械」認證 ，成為中國企業在呼吸介入冷凍治療領域首個獲此國際權威認證的產品，為進軍全球醫療市場奠定基礎。康灃生物在呼吸介入領域構建了極具競爭力的產品矩陣，覆蓋從惡性狹窄、良性狹窄、哮喘、慢阻肺（COPD）、肺周結節、慢性咳嗽到氣道結核等多種重要適應症。其中：惡性狹窄冷凍消融系統已在中國成功商業化；哮喘、慢阻肺系統處於確證性臨床試驗階段，預計2026年獲批；咳嗽、結核、肺周結節等系統也處於不同研發階段；冷凍粘連治療系統含一次性冷凍探頭及可重複使用冷凍探頭已獲批准並上市。這些產品的成功，主要建立在康灃兩大核心技術平台之上--獨特的液氮冷凍消融技術（以液氮為冷媒能量源）和先進的柔性導管技術。該平台提供了深低溫、精確控制、微創介入的能力，在治療效率和安全性上具有顯著優勢，形成了競爭對手難以逾越的技術壁壘。平台價值裂變，多領域布局加速商業化康灃生物的核心價值不僅在於其亮眼的呼吸介入管線，更在於其作為創新型冷凍治療平台企業的稀缺屬性。公司以液氮冷凍技術和柔性導管技術為基石，成功將產品線拓展至多個龐大的治療領域：其中，在血管介入領域：心臟冷凍消融系統（用於房顫治療）已於2024年9月在中國商業化。Cryofocus冷凍消融系統（用於高血壓治療）獲美國食品及藥物管理局「突破性器械」認定，處於確證性臨床階段。肺動脈高壓冷凍消融系統處於臨床前研階段。這些產品涉及的心血管適應症市場空間巨大。在經自然腔道內鏡手術（NOTES）領域：呼吸介入領域如前所述，產品線豐富且領先。腫瘤介入領域如膀胱冷凍消融系統已在中國上市；胃部冷凍消融系統、食道冷凍噴霧治療系統處於臨床試驗階段，瞄準胃癌、食道癌等市場。在非冷凍治療產品方面：如肺結節定位針（已上市）、內鏡吻合夾（已上市）、房顫脈衝電場消融（PFA）系統、抗胃食管反流系統等，形成互補和協同。這種「一平台、多賽道」模式，賦予了康灃生物極強的適應症擴展能力和管線可持續性。公司目前擁有14款冷凍治療產品及在研產品，加上9款非冷凍產品，總計23款產品組成的強大管線庫，其中11款已實現商業化。這種平台化的布局在專注於單一領域的醫療器械公司中極為罕見，展現了巨大的長期增長潛力和抗風險能力。財務表現優異，成長動能持續除了呼吸介入產品所驅動的收入的高增長，康灃生物中期業績還透露出積極的持續成長信號。報告期內，公司技術平台的優勢進一步轉化為財務韌性。2025年6月30日止六個月，康灃生物毛利達3,431萬元，同比增長124.5%；毛利率保持在穩健的67.1%。研發效率提升，虧損顯著改善。數據顯示其研發開支優化至1,791萬元（同比下降51.9%），期內虧損收窄至2,722萬元，同比縮減51.4%，扭虧趨勢明確。現金儲備較2024年底增長40.1%至6,368萬元，為持續研發和市場拓展提供堅實後盾。隨着更多自研高價值產品（如惡性狹窄冷凍消融系統）的上市和放量，以及波科經銷合作的深化，公司收入來源更加多元化且質量提升。報告期內，研發費用的大幅下降並非削減投入，而是研發效率提升和部分產品進入後期階段（減少耗材投入）的結果，員工成本優化和管理改進是關鍵原因。這為公司未來在維持高強度創新的同時控制成本提供了良好範式。此外，公司在銷售網絡建設投入也在加大，報告期內銷售及分銷開支同比增加174.4%至916萬元，反映了公司積極投入資源搭建營銷團隊和推廣新上市產品（如惡性狹窄冷凍消融系統），為未來銷售規模的進一步擴大奠定基礎。對標全球龍頭，估值窪地顯現康灃生物在呼吸介入冷凍治療，特別是在獲得FDA突破性認證的哮喘治療等呼吸介入領域的技術實力，使其具備了與國際領先企業同台競技的潛力。以專注於阻塞性睡眠呼吸暫停（OSA）治療的神經刺激器企業Inspire Medical Systems（INSP）作為參照（雖然適應症不完全相同，但同屬呼吸系統神經介入器械領域）： Inspire Medical目前市值22.79億美元，市盈率（TTM）44.28倍（根據8月7日收盤價）。康灃生物的哮喘冷凍消融系統同樣作用於肺部迷走神經（靶向神經）消融，以微創介入方式治療哮喘，其技術路徑具有創新性且獲得了美國食品及藥物管理局的突破性認可。然而，作為一家覆蓋多領域、擁有豐富管線、且多個產品已商業化的平台型創新公司，康灃生物當前在港股的估值（INSP市值為康灃生物的12.8倍）遠低於Inspire Medical的估值水平。這種巨大的估值差異，固然有市場（美股vs港股）、發展階段（Inspire已盈利且在美國市場成熟）、單一產品vs平台等因素的影響，但也清晰地凸顯出康灃生物當前市值與其技術實力、產品管線廣度和全球化突破潛力相比，存在顯着的提升空間。隨着其呼吸介入產品（尤其是是哮喘冷凍消融系統、慢阻肺冷凍噴霧治療系統、肺周結節冷凍消融系統）臨床進展推進、海外註冊路徑明確以及收入規模的持續高速增長，市場對其價值的重估將是一個大概率事件。當前的估值水平，對於看好微創介入冷凍治療賽道長期前景和平台型企業價值的投資者而言，提供了一個具有吸引力的布局窗口。展望未來，康灃生物的戰略清晰，包括迅速推動在研產品的臨床開發和商業化；專注於微創介入冷凍治療，基於技術平台進一步擴大產品組合；持續研發各種底層技術及配套技術；及選擇性地拓展全球業務。公司正穩步從研發驅動向研發與商業化雙輪驅動轉型，並朝着成為「全球微創介入冷凍治療醫療器械平台」的願景堅實邁進。 Copyright 2025 亞太商訊 via SeaPRwire.com.

香港，2025年8月11日 - (亞太商訊 via SeaPRwire.com) - 8月8日，全國首批數據中心REITs--南方潤澤科技數據中心REIT與南方萬國數據中心REIT正式登陸滬深交易所，上市首日雙雙漲停，分別報收5.850元和3.9元。兩單產品的亮眼表現，不僅標誌著REITs市場正式切入「科技新基建」賽道，也凸顯了產業資本在推動算力基礎設施證券化中的重要作用。作為兩單項目的重要投資方，港股上市公司首程控股（0697.HK）再次站在市場關注的風口。通過全資子公司北京首源欣榮投資有限公司，以及旗下管理的北京平準基礎設施不動產股權投資基金，首程控股分別投資了南方萬國數據中心REIT與南方潤澤科技數據中心REIT。這不僅是公司在數據中心領域的又一次精準布局，更是其深耕REITs市場戰略版圖的最新落子。一、切入「算力底座」，緊抓數字經濟新機遇公開資料顯示，南方萬國數據中心REIT的底層資產為位於昆山花橋的國金數據雲計算數據中心，機櫃數4192個；南方潤澤科技數據中心REIT的底層資產則為位於京津冀國家算力樞紐節點的潤澤（廊坊）國際信息港A-18數據中心，機櫃數5897個，上架率超99%。兩大項目均屬於區域核心算力資源，在支撐5G、人工智能、大數據等應用方面具有不可替代的戰略價值。業內人士指出，數據中心REITs的推出，意味著公募REITs資產類型首次覆蓋到科技創新基礎設施領域，有助於推動算力資源高效配置，提升資本市場服務數字經濟的能力。二、全鏈條布局，構建REITs生態閉環事實上，首程控股在REITs領域的布局早已形成全鏈條覆蓋。自2021年作為首批公募REITs的最大戰略投資者之一，公司便圍繞「Pre-REITs產業基金培育-平台運營管理-公募REITs退出-戰略配售投資」建立了完整的生態體系。截至目前，首程控股REITs基金管理規模已突破300億元，投資領域覆蓋交通樞紐、城市更新、綠色能源、數據中心等多個板塊。今年以來，公司相繼投資了首農產業園REIT、華夏華電清潔能源REIT，並通過北京平準基金與國壽投資、財信人壽等機構合作，設立目標規模100億元的平準基礎設施基金，進一步夯實其在REITs市場的產業資本地位。三、產業資本優勢顯現，助力市場良性發展作為產業資本，首程控股不僅提供資金，更依託自身在智能基礎設施資產管理、運營、整合等方面的能力，為底層資產的運營效率和長期價值提升提供保障。這種「資金+運營」的雙重賦能模式，使公司在REITs市場中形成了與單純財務投資機構的差異化優勢。分析人士認為，隨著公募REITs市場規模的不斷擴容，以及數據中心等新型基礎設施的證券化步伐加快，首程控股有望在「科技新基建+REITs」這一新興交匯賽道上持續受益，並鞏固其在行業內的引領地位。Posted by All Way Success Company Limited for Shoucheng Holdings www.shouchengholdings.com [HKSE:0697, FRA:SHVA, OTCPK:SHNHF] Copyright 2025 亞太商訊 via SeaPRwire.com.

KUALA LUMPUR, Aug 8, 2025 - (ACN Newswire via SeaPRwire.com) - Qube Integrated Malaysia Sdn. Bhd. (Qube), a leading local business events industry player celebrating its 20th anniversary this year, won 10 prestigious awards at the Malaysia Business Events Awards (MBEA) 2025, organised by the Malaysian Association of Convention and Exhibition Organisers and Suppliers (MACEOS) last night.The company, an established name in the MICE (Meetings, Incentives, Conferences and Exhibitions) industry, was honoured at the event held at the Kuala Lumpur Convention Centre with five Excellence Awards and five Merit Awards, out of the 10 categories it was shortlisted for, including:1. Exhibition Management Excellence Award: Qube for Malaysia International Halal Showcase (MIHAS) 20242. Trade Exhibition Excellence Award for events between 10,001–20,000 sqm: BuildXpo Malaysia 20243. Booth Design Excellence Award for booths below 72sqm held in overseas: MyCEB Pavilion at IMEX Frankfurt4. Booth Design Excellence Award for single deck booth 73 sqm & above: Proton Pavilion at KLIMS 20245. Stage Design Excellence Award: Acer APAC Predator League 20256. Trade Exhibition Excellence Merit Award (20,001 sqm and above): MIHAS 20247. Event Excellence (B2B – Corporate) Merit Award: Proton e.MAS 7 Grand Launch8. Booth Design Excellence Merit Award (Double Deck): Malaysia Airlines @ MATTA Fair – March 20249. Merit Award Booth Design Excellence Merit Award (Double Deck): Malaysia Airlines @ MATTA Fair – Sept 202410. Purpose-Built Venue Excellence Merit Award (15,001 sqm and above): Malaysia International Trade and Exhibition Centre (MITEC)Founded in 2005 and headquartered in Kuala Lumpur, Qube marks its 20th anniversary this year with a bold step forward in digital innovation, talent development, and regional collaboration. Reinforcing its long-term commitment to shaping the future of MICE, the company has announced several new initiatives that underline its role as a strategic player in Malaysia’s trade and tourism growth.Over the last two decades, Qube has grown from a boutique design-and-build agency into a powerhouse for creative and executional excellence in exhibitions and events. The company has delivered Malaysia’s pavilions at global showcases, including Expo 2017 Astana and Expo 2020 Dubai, which drew millions of visitors. In 2024, Qube set a significant milestone when the company acquired the tenure to manage the Malaysia International Trade and Exhibition Centre (MITEC), the country’s largest business events venue.In 2024, Qube also acquired SEA Healthcare & Pharma Show (SEACare), a long-running business trade exhibition in the medical and pharma sector. Most recently, Qube designed, built and managed the Malaysia Pavilion at the 2025 Mobile World Congress in Barcelona, and continues to manage MIHAS, the world’s largest halal trade fair and a Guinness World Records title holder.On this achievement, Richard Teo, Executive Chairman of Qube, said: “This recognition means a great deal to us. It reflects the dedication of our team, the trust of our clients, and the strength of the partnerships we have built. These platforms do more than showcase what we can do. They position Malaysian brands globally, create new opportunities for SMEs, and attract long-term business and investment into the country.”“Business events are not just about putting people in the same room. They help drive innovation, stimulate economic activity, support jobs and strengthen supply chains. At the heart of it all, we are focused on creating meaningful impact for our clients, our people and the nation,” he added.Collaboration with the Public SectorQube continues to work closely with public agencies including MATRADE, the Construction Industry Development Board (CIDB), the Malaysia Convention & Exhibition Bureau (MyCEB) and others. These partnerships align with national priorities under the 13th Malaysia Plan and ongoing tourism recovery efforts, particularly in SME development, export growth, talent upskilling and business event-driven tourism.Looking ahead, Qube will play a central role in several major upcoming platforms:MIHAS 2025, in partnership with MATRADESME Venture@ASEAN 2025, with SME Corporation MalaysiaICW & BuildXpo 2025, co-organised with CIDB MalaysiaIn addition, Qube will host its signature event, WE2025: Future in Motion, a flagship initiative for empowering women in business, leadership, and innovation, from 25 to 27 November 2025. Themed Women in Trade. Investment. Leadership., this multi-platform event is organised in collaboration with the Ministry of Women, Family and Community Development and the Department of Women Development.WE2025 features four integrated pillars: a leadership conference, a large-scale trade and investment expo, curated business matching and key side events.Aimed at women entrepreneurs, corporate leaders, SMEs, startups, youth, ecosystem enablers and inclusive industries from across ASEAN and beyond, WE2025: Future in Motion is expected to attract 10,000 visitors, 1,000 delegates, 500 exhibitor booths, and generate RM100 million in trade and investment opportunities.“We have always believed in using our platforms to make a lasting difference. Whether it is through delivering a high-impact trade show, empowering local brands, or raising the bar in venue management, our purpose has remained the same. Our growth is powered by talent, shaped by innovation, and guided by the values of inclusivity and excellence,” added Teo.Contacts for Media Enquiries: MNAIR PR Consultancy Sdn. Bhd.Sashikala NairDirector, Public Relations+6012 566 9095sashi@mnairpr.comShuman VasuAssociate Director, Public Relations+6017 354 6461shumanv@mnairpr.comQube Integrated Malaysia Sdn. Bhd. (Qube)Yasmin BathamanathanManager, PR & Communications+6012 358 9063yasmin@qube.com.my Copyright 2025 ACN Newswire via SeaPRwire.com.

HONG KONG, Aug 11, 2025 - (ACN Newswire via SeaPRwire.com) - On August 8, the first batch of data center REITs—Nanfang Range Technology Data Center REIT and Nanfang Wanguo Data Center REIT—officially debuted on the Shanghai and Shenzhen stock exchanges, both hitting the daily price limit on their first day of trading, closing at RMB 5.850 and RMB 3.9, respectively. Their strong performance marked the official entry of the REITs market into the "tech new infrastructure" arena and underscored the important role of industrial capital in driving the securitization of computing power infrastructure.As a key investor in both projects, Shoucheng Holdings Limited (0697.HK) has once again found itself in the spotlight. Through its wholly-owned subsidiary, Beijing Shouyuan Xinrong Investment Co., Ltd., and the Beijing Pingzhun Infrastructure Real Estate Investment Fund under its management, Shoucheng Holdings invested in both Nanfang Wanguo Data Center REIT and Nanfang Range Technology Data Center REIT. This represents not only another precise move in the data center sector but also the latest step in Shoucheng’s broader REITs market strategy.Tapping into the “Computing Power Base” to Capture Digital Economy GrowthAccording to public information, the Nanfang Wanguo Data Center REIT is backed by the Guojin Data Cloud Computing Center in Huaqiao, Kunshan, with 4,192 racks; the Nanfang Range Technology Data Center REIT is backed by the A-18 Data Center at Runze (Langfang) International Information Port, located in the Beijing-Tianjin-Hebei National Computing Hub, with 5,897 racks and an occupancy rate exceeding 99%. Both assets are core regional computing power resources, playing a vital role in supporting 5G, artificial intelligence, and big data applications.Industry experts note that the launch of data center REITs marks the first time that public REITs in China have covered the technology innovation infrastructure segment, facilitating more efficient allocation of computing resources and enhancing the capital market’s ability to serve the digital economy.Full-Chain Deployment: Building a Closed-Loop REITs EcosystemShoucheng’s involvement in the REITs market has long gone beyond single investments. Since becoming one of the largest strategic investors in China’s inaugural public REITs in 2021, the company has built a complete ecosystem covering “Pre-REITs industrial fund incubation — platform operations — public REITs exit — strategic placement investment.”Currently, Shoucheng’s REITs fund management scale exceeds RMB 30 billion, with investments spanning transportation hubs, urban renewal, green energy, and data centers. In 2025 alone, the company has invested in the Sunlon REIT and the Huadian REIT, and through the Beijing Pingzhun Infrastructure Real Estate Investment Fund, partnered with China Life Investment and Caixin Life Insurance to launch a RMB 10 billion Pingzhun Infrastructure Fund, further strengthening its position as a leading industrial capital player in the REITs market.Industrial Capital Advantage: Driving Sustainable Market DevelopmentAs an industrial capital investor, Shoucheng Holdings not only provides funding but also leverages its expertise in asset management, operations, and integration of intelligent infrastructure to enhance both the operational efficiency and long-term value of underlying assets. This “capital + operations” dual empowerment model differentiates the company from pure financial investors in the REITs market.Analysts believe that with the ongoing expansion of China’s public REITs market and the acceleration of securitization in emerging infrastructure such as data centers, Shoucheng Holdings is well-positioned to benefit from the convergence of “new tech infrastructure + REITs” and to consolidate its leadership in the sector.Posted by All Way Success Company Limited for Shoucheng Holdings www.shouchengholdings.com [HKSE:0697, FRA:SHVA, OTCPK:SHNHF] Copyright 2025 ACN Newswire via SeaPRwire.com.